News Release

Study supports the use of mechanical assistance

for acute or chronic heart failure in high-risk patients

Peer-Reviewed Publication

Blackwell Publishing Ltd.

The success of long-term implantable ventricular assist devices (LVAD) or artificial hearts has led to their increased use in patients previously thought to be unsuitable for mechanical support. This study documents the shift in the demographic profile of patients in need of artificial hearts to a more high-risk group. Looking at clinical records of 131 consecutive recipients receiving LVAD as a bridge to transplantation, it was discovered that despite the patients' high-risk status, overall mortality rate remained high at 50%.

"The results continue to emphasize that patient selection is the predominant criteria for success in artificial heart programs, but that high-risk patients can be helped in experienced centers" states Dr.Vivek Rao, author of the article published in a recent issue of the Journal of Cardiac Surgery .

Mechanical circulatory assistance has emerged as a standard of care for the treatment of acute and chronic heart failure to conventional medical therapy. Results of this study could have implications for funding of artificial heart programs whereby more patients in the high-risk category will be candidates for mechanical assist.

###

This study is published in the Journal of Cardiac Surgery. Media wishing to receive a PDF of this article please contact medicalnews@bos.blackwellpublishing.net.

About the Author
Dr. Vivek Rao is currently the Surgical Director of Heart Transplantation and Mechanical Circulatory Assistance at theToronto General Hospital. He completed his medical and surgical training at the University of Toronto prior to completing a fellowship in cardiac transplantation and mechanical circulatory support at New York's Columbia-Presbyterian Hospital. For more information about this study, please contact him by email at Vivek.Rao@uhn.on.ca.

About the Journal of Cardiac Surgery
Journal of Cardiac Surgery (JCS) is a peer-reviewed journal devoted to contemporary surgical treatment of cardiac disease. Renown for its detailed "how to" methods, JCS's well-illustrated, concise technical articles, critical reviews and commentaries are highly valued by dedicated readers worldwide.

About Blackwell Publishing
Blackwell Publishing is the world's leading society publisher. The company remains independent with over 900 staff members in offices in the US, UK, Australia, China, Denmark, Germany, and Japan. Blackwell publishes over 700 journals in partnership with more than 550 academic and professional societies.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.